Wealthstar Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$675K Buy
34,603
+1,041
+3% +$20.7K 0.2% 63
2026
Q1
$645K Sell
33,562
-1,298
-4% -$25.6K 0.3% 70
2025
Q4
$660K Sell
34,860
-15
-0% -$278 0.29% 64
2025
Q3
$650K Sell
34,875
-4,629
-12% -$86.5K 0.26% 72
2025
Q2
$728K Sell
39,504
-2,410
-6% -$42.8K 0.27% 67
2025
Q1
$732K Buy
41,914
+3,790
+10% +$63.9K 0.34% 65
2024
Q4
$660K Buy
+38,124
New +$696K 0.29% 66
2024
Q2
Sell
-39,997
Closed -$591K 117
2024
Q1
$591K Buy
39,997
+3,212
+9% +$44.5K 0.21% 63
2023
Q4
$525K Buy
36,785
+17,501
+91% +$249K 0.08% 75
2023
Q3
$269K Buy
+19,284
New +$247K 0.1% 87

Other funds holding SBRA

Wealthstar Advisors's SBRA Position: Q2 2026 in Review

Wealthstar Advisors increased its Sabra Healthcare REIT (SBRA) stake by 3.1% in Q2 2026, buying an estimated $20.7K and bringing the position to 34,603 shares worth $675K. The position accounts for 0.2% of the portfolio, ranked #63.

Wealthstar Advisors first reported a position in SBRA in Q3 2023 and has held it in 10 quarters since. The position peaked at $732K in Q1 2025. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Wealthstar Advisors held 34,603 shares of Sabra Healthcare REIT worth $675K as of Q2 2026.
  • Wealthstar Advisors bought 1,041 Sabra Healthcare REIT shares in Q2 2026, an estimated $20.7K.
  • Sabra Healthcare REIT made up 0.2% of Wealthstar Advisors's portfolio in Q2 2026, its #63 holding.
  • Wealthstar Advisors first reported a position in Sabra Healthcare REIT in Q3 2023 and has held it in 10 quarters since.
  • Wealthstar Advisors's Sabra Healthcare REIT position peaked at $732K in Q1 2025.
  • 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Wealthstar Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.